National Comprehensive Cancer Network
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Abstract
The NCCN Guidelines for Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer provide multidisciplinary diagnostic workup, staging, and treatment recommendations for this disease. These NCCN Guidelines Insights detail how the evolution of the use of PARP inhibitors as maintenance and single-agent regimens for the treatment of ovarian cancer informed panel recommendations in the guidelines.
Source and rights
Published by Journal of the National Comprehensive Cancer Network : JNCCN, 2024. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- National Comprehensive Cancer Network
- Published
- 2024
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Journal of the National Comprehensive Cancer Network : JNCCN
- PubMed
- 39413835
- Added to Prognia
- 22 July 2026
More in obstetrics and gynaecology
- Expert opinion by the Italian Society of Gynecology of the Third Age (SIGiTE) and the Italian Society of Menopause (SIM) on diagnosis and treatment of premature ovarian insufficiencyEuropean Respiratory Society · 2026
- Preexisting diabetes: Expert consensus from the College of French Gynecologists and Obstetricians and from the French Society of DiabetologyCollege of French Gynecologists and Obstetricians and French Society of Diabetology · 2026
